龍馬環衞(603686.SH):2月新增預中標2個環衞服務項目
格隆匯3月8日丨龍馬環衞(603686.SH)公佈,公司2021年2月新增預中標了內蒙古自治區鄂爾多斯市、海南省臨高縣等地的環衞服務項目及簽訂天津市新尚園小區物業服務項目合同。
公司本月預中標的環衞服務項目中標數2個,簽訂1個小區物業服務項目合同,合計首年服務費金額為1.05億元(佔公司2019年度經審計營業收入的2.48%),合同總金額為12.85億元,若能夠簽訂正式項目合同並順利實施,將對公司2021年及以後的經營業績產生積極影響。
截至2021年2月28日,公司2021年環衞服務項目中標數6個,合計首年年度金額為16,772.26萬元,合同總金額15.18億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.